Radical cystectomy vs. chemoradiation in T2-4aN0M0 bladder cancer: a case-control study.

BACKGROUND: Muscle-invasive bladder cancer is most commonly treated by radical cystectomy. Patients who are too sick to go through this surgery or who are unwilling to accept the mutilation associated with it are referred to chemoradiation. We compared the results of these 2 modalities using age-matched populations. PARTICIPANTS AND METHODS: Between 1998 and 2008, 33 patients were treated with chemoradiation for biopsy-proven T2-4aN0M0 urothelial bladder cancer. For every patient treated with chemoradiation, an age-matched patient who underwent radical cystectomy on the same year was selected for comparison. Mean radiotherapy dose was 62 Gy (standard deviation = 8.4) and median follow-up of both groups was approximately 36 months. RESULTS: The groups were similar in age, proportion of men, and length of follow-up. However, the Charlson comorbidity index was significantly lower for operated patients (3.45 vs. 4.36, P = 0.01). Furthermore, 2 patients (6%) in the chemoradiation group had salvage cystectomy (one for disease recurrence and another for bladder shrinkage). The 2- and 5-year overall survival rates after surgery were 74.4% and 54.8%, respectively, and after chemoradiation were 70.2% and 56.6% (P = 0.8), respectively. The 2- and 5-year disease-free survival rates after surgery were 67.8% and 63.2%, respectively, and after chemoradiation were 63% and 54.3% (P = 0.89), respectively. Side effects were mild in both groups, with grade 3+toxicity seen in only 2 operated and 4 irradiated patients. CONCLUSIONS: Despite having a significantly higher comorbidity index, patients treated with chemoradiation had similar overall and disease-free survival rates with low toxicity. Treatment with chemoradiation should be considered in patients with T2-4aN0M0 bladder cancer.

Effects of water vapor density on cutaneous resistance to evaporative water loss and body temperature in green tree frogs (Hyla cinerea).

Increased cutaneous resistance to evaporative water loss (Rc) in tree frogs results in decreased water loss rate and increased body temperature. We examined sensitivity of Rc to water vapor density (WVD) in Hyla cinerea by exposing individual frogs and agar models to four different WVD environments and measuring cutaneous evaporative water loss rate and body temperature simultaneously using a gravimetric wind tunnel measuring system. We found that water loss rate varied inversely and body temperature directly with WVD but that models were affected to a greater extent than were animals. Mean Rc was significantly different between the highest WVD environment and each of the three drier environments but did not differ among the drier environments, indicating that Rc initially increases and then reaches a plateau in response to decreasing WVD. Rc was equivalent when calculated using either WVD difference or WVD deficit as the driving force for evaporation. We also directly observed secretions from cutaneous glands while measuring body temperature and tested secretions and skin samples for the presence of lipids. We found that irregular transient body temperature depressions observed during wind tunnel trials occur due to evaporative cooling from intermittent skin secretions containing lipids, although we were unable to identify lipid-secreting glands.

Hyperbaric oxygen therapy for hemorrhagic radiation cystitis.

BACKGROUND: Hemorrhagic radiation cystitis (HRC) is a significant clinical problem that occurs after pelvic radiation therapy and is often refractory. OBJECTIVES: To evaluate the efficacy and safety of hyperbaric oxygen therapy (HBO) for HRC. METHODS: Daily 90 minute sessions of HBO at 2 ATM 100% oxygen were given to 32 HRC patients with ASTRO grades 3-4 hematuria. RESULTS: The median age was 72.5 (48-88 years). The median time interval between radiation therapy and HBO was 4 years (1-26 years). The patients received a median of 30 HBO sessions (3-53). Hematuria resolved in 27 patients (84%) and persisted in 5. Cystectomy was required in two, and ileal-conduit and bilateral percutaneous nephrostomies were performed in one and two patients, respectively. With a median follow-up of 12 months (5-74 months), the hematuria cleared completely in 16 patients (59%) and mild hematuria requiring no further treatment recurred in 10 others. Another patient with ASTRO grade 4 hematuria needed bladder irrigation and blood transfusions. Complications included eardrum perforation in four patients and transient vertigo and mild hemoptysis in one case each. None of them required HBO discontinuation. CONCLUSIONS: HBO controlled bleeding in 84% of the patients. A durable freedom from significant hematuria was achieved in 96% of the patients. HBO seems to be an effective and safe modality in patients with HRC.

Brain metastases: a rare initial presentation of prostate cancer.

Although brain metastases are common in cancer patients, carcinoma of the prostate rarely metastasizes to the brain. Cerebral metastases as an initial clinical presentation of prostate carcinoma are extremely rare. We report a patient, who presented with confusion and behavioral changes. Cranial magnetic resonance imaging revealed a large right temporal lobe lesion. The pathological diagnosis of the tumor was consistent with metastatic prostate carcinoma. Further evaluation revealed widespread bony metastases by technetium 99 bone scan and high level of prostate-specific antigen.